User:Mr. Ibrahem/Abametapir

Abametapir, sold under the brand name Xeglyze, is a medication used to treat head lice infestation. It can be used in people at least six months old. It is applied to the hair and scalp.

Common side effects include skin redness, rash, burning, vomiting, eye irritation, itching, and hair color changes. If swallowed, it can result in benzyl alcohol toxicity. While there is no evidence of harm in pregnancy, such use has not been well studied. It is a metalloproteinase inhibitor.

Abametapir was approved for medical use in the United States in 2020. It is not approved in either the United Kingdom or Europe as of 2022. It is not commercially available in the United States as of 2022.